John McNeish
Executive Director, Pfizer Regenerative Medicine
John McNeish is Executive Director of Regenerative Medicine in Pfizer's Global Research and Development unit in Cambridge, Massachusetts. In this role he builds on his research interests in stem-cell-based regenerative medicine targets and therapeutics. He has co-authored numerous articles and book chapters on the use of genetically modified mice and stem cells. McNeish serves on the editorial board of Regenerative Medicine and holds an adjunct faculty position at Connecticut College. In 2007, he was the recipient of the W.E. Upjohn award, Pfizer's highest award, for his research in novel applications of stem cells in drug discovery. Prior to joining Pfizer in 1992, he did postdoctoral research focusing on stem-cell technology with the Nobel laureate Oliver Smithies at the University of North Carolina. McNeish received his Ph.D. in developmental biology from the University of Cincinnati, where he applied transgenic technologies to the identification of critical mammalian developmental pathways.
Panel:
The State of Stem Cell Research
| 
